Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank86
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
85.00%
↑ 134% vs avg
Percentile
P86
Within normal range
Streak
3 yr
Consecutive growthAccelerating
Average
-250.21%
Historical baseline
PeriodValue
202585.00%
202429.33%
2023-139.63%
2022-1408.16%
2021117.73%
2020-475.50%
2019-210.48%
20180.00%